DR Joanna Sanford sp. k.

Other health care activities

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2017-09-07
Limited partner contribution
5,000.00 PLN
Activity description

Dr Joanna Sanford is the founder of Sanford Biotech, which develops stem cell therapies and growth factor treatments for both human and veterinary medicine. The company conducts translational research to create commercial cell therapies with high licensing potential, including innovative treatments for conditions like arthritis in dogs and atopic dermatitis in pets. Additionally, Sanford Biotech is involved in advanced therapies for horses and dairy cattle, reflecting a shift in the care of these animals towards more human-like medical attention.

Registered address
Aleja Marsz. Józefa Piłsudskiego 35E, 05-077 Warszawa, Poland
Opening hours
Mon–Fri, 9:00–16:00
Email
Phone
Electronic delivery address
AE:PL-73817-96606-CGSGR-21

Financials

Revenue history (in k)

Filing timeliness

4 of 6 financial statements were filed late (the longest delay 130 days for 2021).

  • 202514/07/2026
  • 202410/07/2025
  • 202304/11/2024
  • 202218/07/2023
  • 202122/11/2022
  • 202018/11/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Other health care activities90 / 120
Top 75%
Division · Human health activities5,775 / 6,271
Top 92%
Top 92%
City · Warszawa44,069 / 56,729
Top 78%
Voivodeship · Mazowieckie60,971 / 76,892
Top 79%
Country · Poland240,023 / 297,069
Top 81%

Results vs industry

Revenue
This companyUSD 28.67kMedianUSD 126.45kAverageUSD 1.66m
Net profit
This companyUSD 9.64kMedianUSD 6.63kAverageUSD 183.26k
Operating costs
This companyUSD 19.03kMedianUSD 100.07kAverageUSD 1.46m
Assets
This companyUSD 24.20kMedianUSD 58.09kAverageUSD 709.77k

Offer

  • Stem cell therapies
  • Platelet-rich plasma therapy
  • Biological therapies
  • Translational research
  • Veterinary therapies

Websites

  • sanfordbiotech.comSanford Biotech | komórki macierzyste i badania translacyjne
    Google AnalyticsGoogle Tag ManagerLiteSpeed

Partners

Manner of representation

Each partner authorized to represent the company has the right to represent the company independently.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2017-11-01.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

68 public aid cases recorded, with a total value of $22,848.

PurposeGross amount
Aid in the form of wage subsidies for the recruitment of workers with disabilities
$338
Aid in the form of wage subsidies for the recruitment of workers with disabilities
$338
Aid in the form of wage subsidies for the recruitment of workers with disabilities
$338

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
ETG Zamość sp. z o.o.
Nanosanguis S.A.
Medesto sp. z o.o.
WPD Pharmaceuticals S.A.
Orphinic Scientific S.A.
Bonereg sp. z o.o.
Cellis sp. z o.o.
Nanovelos S.A.
Microbiota Med sp. z o.o.
Omniseptica sp. z o.o.

Change history

DateEvent
2025-09-29Name change
2025-09-29Switch to PKD 2025
2017-09-07Entered in the register

FAQ

Last updated: 2026-07-17